Skip to main content

Table 4 Polyunsaturated fatty acids levels in all patients according to statin use

From: The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study

 

Statin use

P value

-

+

 

N

813

920

 

EPA, μg/mL

73.0 ± 43.9

74.6 ± 44.1

0.46

DHA, μg/mL

146.8 ± 57.4

140.5 ± 48.1

<0.05

AA, μg/mL

154.2 ± 57.6

160.3 ± 40.9

<0.01

DHLA, μg/mL

32.2 ± 12.8

34.1 ± 11.8

<0.05

EPA/AA

0.50 ± 0.30

0.49 ± 0.31

0.6

DHA/AA

0.99 ± 0.44

0.91 ± 0.32

<0.0001

  1. Fatty acids (EPA, DHA, AA and DHLA) profile with or without statin use in all study patients
  2. Abbreviations are listed in the footnote to Table 1